Sandi See Tai
Corporate Officer/Principal bij LEXEO THERAPEUTICS, INC.
Vermogen: 276 474 $ op 31-05-2024
Profiel
Sandi See Tai is currently the Chief Development Officer at Lexeo Therapeutics, Inc. Prior to this, Sandi worked as the Vice President-Development & Head-Rare Disease at Pfizer Inc. Sandi also served as an Assistant Professor-Pediatrics at Drexel University College of Medicine from 2001 to 2004.
From 2004 to 2020, Sandi worked as a Principal at Wyeth Pharmaceuticals LLC.
Sandi holds a doctorate degree from Tufts University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LEXEO THERAPEUTICS, INC.
0.05% | 05-02-2024 | 16 625 ( 0.05% ) | 276 474 $ | 31-05-2024 |
Actieve functies van Sandi See Tai
| Bedrijven | Functie | Begin |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Corporate Officer/Principal | 05-02-2024 |
Eerdere bekende functies van Sandi See Tai
| Bedrijven | Functie | Einde |
|---|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 01-03-2020 |
| Drexel University College of Medicine | Corporate Officer/Principal | 01-01-2004 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Opleiding van Sandi See Tai
| Tufts University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LEXEO THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
